MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

Strona główna・Stock List・Treace Medical Concepts Inc

Treace Medical Concepts Inc

Closed

5.94 1.54

Buy Sell

Overview

Share price change

24h

Current

Min

5.77

Max

6.06

Key metrics
By Trading Economics
Income	-1.5M -17M
Sales	-5.2M 47M
Profit margin	-36.715
Employees	477
EBITDA	-1.4M -14M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+40.99% upside

Dividends
By Dow Jones
Next Earnings	4 lis 2025

Market Stats
By TradingEconomics
Market Cap	45M 398M
Previous open	4.4
Previous close	5.94

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

7.16 / 7.65 Support & Resistance

Treace Medical Concepts Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

13 paź 2025, 21:45 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million -- Update

13 paź 2025, 21:07 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million

13 paź 2025, 17:03 UTC

Major Market Movers

Canaan ADRs Climb on Launch of Gas-to-Computing Pilot in Canada

13 paź 2025, 23:53 UTC

Market Talk

Gold Rises, Buoyed by Bullish Fundamental Backdrop -- Market Talk

13 paź 2025, 23:39 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

13 paź 2025, 22:15 UTC

Market Talk

Global Equities Roundup: Market Talk

13 paź 2025, 22:15 UTC

Market Talk

Precinct Properties NZ's Equity Raising Looks Opportunistic -- Market Talk

13 paź 2025, 21:57 UTC

Acquisitions, Mergers, Takeovers

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 paź 2025, 21:36 UTC

Market Talk

Global Equities Roundup: Market Talk

13 paź 2025, 21:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

13 paź 2025, 21:36 UTC

Market Talk

Fletcher's Near-Term Headwinds Don't Cloud Earnings Opportunity -- Market Talk

13 paź 2025, 21:30 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs to Acquire Industry Ventures for Up to $965M -- Update

13 paź 2025, 21:06 UTC

Acquisitions, Mergers, Takeovers

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 paź 2025, 20:52 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs to Acquire Industry Ventures for Up to $965M

13 paź 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

13 paź 2025, 20:35 UTC

Acquisitions, Mergers, Takeovers

Goldman Expects to Close Deal in 1Q

13 paź 2025, 20:34 UTC

Acquisitions, Mergers, Takeovers

Industry Ventures Will Be Part of Goldman's External Manager Platform, External Investing Group

13 paź 2025, 20:33 UTC

Acquisitions, Mergers, Takeovers

Industry Ventures Currently Manages $7B of Assets Under Supervision

13 paź 2025, 20:32 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs: Deal to Include Up to $300M of Additional Contingent Consideration Based on Future Performance Through 2030

13 paź 2025, 20:31 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs: Consideration to Include $665M Cash and Equity Payable at Closing

13 paź 2025, 20:29 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs to Buy VC Firm Industry Ventures

13 paź 2025, 19:05 UTC

Market Talk

Oil Futures Pick Up on Easing U.S.-China Tension -- Market Talk

13 paź 2025, 18:59 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

13 paź 2025, 18:26 UTC

Market Talk

Precious Metals Close at New Record Highs -- Market Talk

13 paź 2025, 18:10 UTC

Market Talk

Global Equities Roundup: Market Talk

13 paź 2025, 18:10 UTC

Market Talk

Broadcom's OpenAI Deal Highlights AI Opportunity -- Market Talk

13 paź 2025, 17:05 UTC

Market Talk

Global Equities Roundup: Market Talk

13 paź 2025, 17:05 UTC

Market Talk

OpenAI Deal Offers Huge Upside to Broadcom's Earnings -- Market Talk

13 paź 2025, 16:03 UTC

Acquisitions, Mergers, Takeovers

Umicore Completes Sale, Subsequent Lease-in of Permanent Gold Inventories

13 paź 2025, 15:35 UTC

Market Talk

Precious Metals Push Record Highs Further -- Market Talk

Peer Comparison

Price change

Treace Medical Concepts Inc Forecast

Price Target

By TipRanks

40.99% upside

12 Months Forecast

Average 8.29 USD 40.99%

High 12 USD

Low 6 USD

Based on 7 Wall Street analysts offering 12 month price targets forTreace Medical Concepts Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

7 ratings

Buy

Hold

Sell

Based on 7 analysts giving stock ratings to Treace Medical Concepts Inc - Dist in the past 3 months.

Technical Score

By Trading Central

7.16 / 7.65Support & Resistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.